These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17321186)

  • 1. [Minutes of the 48th meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). Philadelphia (United States), 5-9 November 2006].
    Simon JM; Mazeron JJ
    Cancer Radiother; 2007 May; 11(3):154-7. PubMed ID: 17321186
    [No Abstract]   [Full Text] [Related]  

  • 2. [Minutes of the 25th Meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO). Leizig (Germany), 8-12 October 2006].
    Mazeron JJ
    Cancer Radiother; 2007 May; 11(3):150-3. PubMed ID: 17158083
    [No Abstract]   [Full Text] [Related]  

  • 3. [Minutes of the 49th Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Los Angeles (USA), October 28-November 1 2007].
    Mazeron JJ
    Cancer Radiother; 2008 Jan; 12(1):68-72. PubMed ID: 18262816
    [No Abstract]   [Full Text] [Related]  

  • 4. [Report of the 38th meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Los Angeles, 27-31 October 1996].
    Coquard R; Bachaud J
    Cancer Radiother; 1997; 1(1):88-93. PubMed ID: 9265539
    [No Abstract]   [Full Text] [Related]  

  • 5. ASTRO plenary session touts top new research. American Society for Therapeutic Radiology and Oncology.
    Volkers N
    J Natl Cancer Inst; 1999 Dec; 91(24):2075-7. PubMed ID: 10601375
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
    Stroup SP; Cullen J; Auge BK; L'Esperance JO; Kang SK
    Cancer; 2007 Sep; 110(5):1003-9. PubMed ID: 17614338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [48th meeting of the American Society for Therapeutic Radiology and Oncology (Astro)].
    Simon JM; Mazeron JJ;
    Bull Cancer; 2007 Feb; 94(2):229-32. PubMed ID: 17337392
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy.
    Stock RG; Klein TJ; Cesaretti JA; Stone NN
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):753-8. PubMed ID: 19084351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Minutes of the 51st Meeting of the American Society for Therapeutic Radiology and Oncology (Astro). Chicago (USA), November 1-5, 2009].
    Mazeron JJ
    Bull Cancer; 2010 Jan; 97(1):170-6. PubMed ID: 20007070
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy.
    Pickles T;
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1355-9. PubMed ID: 16406391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation.
    Vicini F; Arthur D; Wazer D; Chen P; Mitchell C; Wallace M; Kestin L; Ye H
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):977-84. PubMed ID: 20510540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic methodology for the biochemical recurrence of prostate cancer after radiotherapy].
    Pijoan JM
    Arch Esp Urol; 2006 Dec; 59(10):1053-62. PubMed ID: 17283718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy.
    Cheung R; Tucker SL; Lee AL; Dong L; Kamat A; Pisters L; Kuban DA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):14-9. PubMed ID: 15629589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Minutes of the 54(th) meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Boston (USA), 28-31 October 2012].
    Thariat J; Mazeron JJ
    Bull Cancer; 2012 Dec; 99(12):1219-26. PubMed ID: 23192678
    [No Abstract]   [Full Text] [Related]  

  • 15. Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?
    Nielsen ME; Makarov DV; Humphreys E; Mangold L; Partin AW; Walsh PC
    Urology; 2008 Aug; 72(2):389-93; discussion 394-5. PubMed ID: 18279937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical recurrence criteria after radiotherapy (external beam, brachytherapy). Natural history of the disease after radiotherapy].
    Villoslada CI; Olombrada MV; San Segundo CG
    Arch Esp Urol; 2012; 65(1):12-20. PubMed ID: 22318174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer.
    Denham JW; Kumar M; Gleeson PS; Lamb DS; Joseph D; Atkinson C; Matthews J; Tai KH; Spry NA; Christie D; Turner S; Greer PB; D'Este C; Steigler A
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):404-11. PubMed ID: 19176272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
    Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
    J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Minutes of the 27th meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO), Goteborg (Sweden), 14-18 September 2008, and of the 50th meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Boston (USA), September 21-25 2008].
    Mazeron R; Mazeron JJ
    Cancer Radiother; 2009 Jun; 13(3):229-36. PubMed ID: 19297225
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer.
    Vora SA; Wong WW; Schild SE; Ezzell GA; Halyard MY
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1053-8. PubMed ID: 17398023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.